Pathfinder Endoscope Overtube
NEPTUNE MEDICAL INC. · Decision date Sep 18, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision for K262262 on September 18, 2026, clearing the Pathfinder Endoscope Overtube from Neptune Medical, Inc. under 21 CFR 876.1500, Class II, product code FED, in the gastroenterology and urology panel. The submission was received July 2, 2026. The device is a non-sterile, single-use overtube used with compatible flexible gastrointestinal endoscopes; a rotating handle connects an internal volume to vacuum to switch the overtube between flexible and rigid states.
The submission cites the applicant's own cleared Pathfinder overtubes, K191415 and K211301, as predicates, with the same indications and nine sizes from 65 to 145 cm long and 11 to 16 mm inner diameter. The stated change is a design modification for compatibility with accessories used in mucosal resection, and the summary describes bench testing across simulated use, rigidization cycling, trackability and handle strength. The summary does not quantify clinical performance, and no post-market clinical data are presented.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Gastroenterology, Urology
- Decision date
- Sep 18, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262262
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- NEPTUNE MEDICAL INC.
- Product code
- FED
- Decision code
- SESE
- Decision date
- Sep 18, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Endoscopic Access Overtube, Gastroenterology-Urology.
- Applicant
- NEPTUNE MEDICAL INC.
- Product code
- FED
- FDA device class
- 2
FDA decision timeline
K262262 received
Application receipt date recorded by FDA.
K262262 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code FED
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Yangzhou Fartley Medical Instrument Technology Co., Ltd. | 510(k) clearance | Sep 21, 2026 | FDA | |
| Zhejiang Chuangxiang Medical Technology Co., Ltd. | 510(k) clearance | Sep 11, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
NEPTUNE MEDICAL INC.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Burlingame, CA
Sources and methodology
- Original FDA record: K262262
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
